SCHEMBL2724088

SCHEMBL2724088

CC(=O)c1ccc(NC(=O)c2cc(I)ccc2O)cc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.52
NPC1 O15118 4/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
MAPT P10636 2/20 0.52
F10 P00742 4/20 0.52
PLAU P00749 4/20 0.52
PLAT P00750 4/20 0.52
F2 P00734 3/20 0.52
P2RX1 P51575 2/20 0.51
ALOX15 P16050 1/20 0.49
TOP1 P11387 1/20 0.49
POLB P06746 2/20 0.47
KMT2A Q03164 1/20 0.47
KCNMA1 Q12791 1/20 0.47
HSP90AA1 P07900 1/20 0.46
HSP90AB1 P08238 1/20 0.46
TMPRSS4 Q9NRS4 1/20 0.46
AHR P35869 1/20 0.45
TDP1 Q9NUW8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2170423 0.88 P2RX1 (0.60) F10PLAUPLATF2P2RX1
SCHEMBL30887951 0.88 P2RX1 (0.60) F10PLAUPLATF2P2RX1
SCHEMBL18341044 0.82 P2RX1 (0.77) RAB9ANPC1SMN1; SMN2MAPTP2RX1
SCHEMBL11683814 0.82 PLAU (0.58) RAB9ANPC1SMN1; SMN2MAPTF10
SCHEMBL14223810 0.82 P2RX1 (0.77) P2RX1POLBKMT2AKCNMA1TMPRSS4
SCHEMBL7197436 0.81 TMPRSS4 (0.67) RAB9ANPC1P2RX1ALOX15POLB
SCHEMBL13997576 0.79 P2RX1 (0.51) F10PLAUPLATF2P2RX1
SCHEMBL2724086 0.79 LMNA (0.53) RAB9ANPC1SMN1; SMN2KMT2AKCNMA1
SCHEMBL19040075 0.79 PLAU (0.66) RAB9ANPC1SMN1; SMN2F10PLAU
SCHEMBL7172677 0.79 TMPRSS4 (0.63) RAB9ANPC1SMN1; SMN2MAPTP2RX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1085848-B1 INHIBITORS OF TRANSCRIPTION FACTOR NF-KAPPA B SMITHKLINE BEECHAM CORP (US) 2008-01-16 EP claimed
US-20150139973-A1 OPHTHALMOLOGICAL VEHICLE SYSTEM FOR DRUGS, OPHTHALMOLOGICAL KIT AND ALSO USE OF AN OPHTHALMOLOGICAL COMPOSITION F. HOLZER GMBH (DE) 2015-05-21 US disclosed
EP-2664329-A1 Ophthalmological vehicle system F. Holzer GmbH (DE) 2013-11-20 EP disclosed
EP-2664330-A1 Composition and medication containing Omega 3 fatty acids and a glucosaminoglucan F. Holzer GmbH (DE) 2013-11-20 EP disclosed
EP-2635266-A1 COMPOSITION AND DRUG CONTAINING OMEGA-3 FATTY ACIDS, AND A MODULATOR F. Holzer GmbH (DE) 2013-09-11 EP disclosed
WO-2012059158-A1 COMPOSITION AND DRUG CONTAINING OMEGA-3 FATTY ACIDS, AND A MODULATOR F. HOLZER GMBH (DE) 2012-05-10 WO disclosed
EP-1085848-B1 INHIBITORS OF TRANSCRIPTION FACTOR NF-KAPPA B SMITHKLINE BEECHAM CORP (US) 2008-01-16 EP disclosed